Cancer is one of the main causes of death in dogs and cats. What was once considered a death sentence is now a disease that can be treated and in most cases, it is possible to extend survival times with good quality of life. Antineoplastic treatment is usually a combination of multiple therapeutic modalities, in which surgery plays an important role for diagnosis and local control of the disease. Chemotherapy, and most recently immunotherapy, help in the systemic control of the remaining disease. Other modalities such as electrochemotherapy, radiotherapy and cryosurgery can also help in the management of cancer patients. In Mexico, oncology is still a novel medical specialty, but one in constant development.
Resúmen
El cáncer es una de las principales causas de deceso en perros y gatos. Lo que antes sé consideraba una sentencia de muerte ahora es una enfermedad tratable, y en la mayoría de los casos es posible extender tiempos de supervivencia con buena calidad de vida. El tratamiento antineoplásico suele ser una combinación de múltiples modalidades terapéuticas, en el que la cirugía juega un papel importante para el diagnóstico y control local de la enfermedad. La quimioterapia, y más recientemente la inmunoterapia, contribuye al control sistémico del padecimiento residual. Herramientas como la electroquimioterapia, radioterapia y criocirugía tienen también un lugar en el cuidado de los pacientes oncológicos. La oncología es una rama de la medicina veterinaria aún joven, pero en constante desarrollo en nuestro país.
Ene | Feb | Mar | Abr | May | Jun | Jul | Ago | Sept | Oct | Nov | Dic |
---|---|---|---|---|---|---|---|---|---|---|---|
- | 8 | 38 | 26 | 23 | 12 | 17 | 22 | 15 | 13 | 18 | 8 |
Ene | Feb | Mar | Abr | May | Jun | Jul | Ago | Sept | Oct | Nov | Dic |
---|---|---|---|---|---|---|---|---|---|---|---|
8 | 13 | 14 | 13 | 18 | 35 | 17 | 14 | 16 | 22 | 29 | 10 |
Ene | Feb | Mar | Abr | May | Jun | Jul | Ago | Sept | Oct | Nov | Dic |
---|---|---|---|---|---|---|---|---|---|---|---|
15 | 21 | 17 | 9 | 15 | - | - | - | - | - | - | - |
Abbas, A. K., Lichtman, A. H. & Pillai, S. (2018a). Anticuerpos
y antígenos. En Inmunología celular y molecular
(pp. 97-116). Elsevier Inc.
Abbas, A. K., Lichtman, A. H. & Pillai, S. (2018b). Inmunidad
antitumoral. En Inmunología celular y molecular
(pp. 397-416). Elsevier Inc.
Abbas, A. K., Lichtman, A. H., & Pillai, S. (2018c).
Propiedades y generalidades de las respuestas inmunitarias.
En Inmunología celular y molecular (pp.
1-12). Elsevier Ltd.
American Veterinary Medical Association (AVMA).
(20 de junio de 2021). Cancer in pets. Recuperado
petcare/cancer-pets
Argyle, D. J. (2020). Molecular/Targeted therapy
of cancer. En S. Withrow (ed.), Small Animal Clinical
Oncology (pp. 251-285). Elsevier Inc.
Arroyo León, Erika. (2021). Inmunoterapia en cáncer
de perros y gatos: Anticuerpos monoclonales como
terapia complementaria: Estudio de revisión. Tesis
de licenciatura no publicada. Universidad Nacional
Autónoma de México.
Barrera, L., Borbolla Escoboza, J. R. & Arrieta Rodríguez,
O. G. (2016). Inmunoterapia del cáncer. En Tratamiento
del cáncer. Oncología médica, quirúrgica y radioterapia
(pp. 185-199). México: Manual Moderno.
Bergman, P. J. (2017). Veterinary Oncology
Immunotherapies. Veterinary Clinics of North
America-Small Animal Practice, 48(2), 257-277. doi.
org/10.1016/j.cvsm.2017.10.004
Bergman, P. J., Camps-Palau, M. A., McKnight, J. A.,
Leibman, N. F., Craft, D. M., Leung, C., Liao, J., Riviere, I.,
Sadelain, M., Hohenhaus, A. E., Gregor, P., Houghton, A.
N., Perales, M. A. & Wolchok, J. D. (2006). Development
of a xenogeneic DNA vaccine program for canine
malignant melanoma at the Animal Medical Center.
Vaccine, 24(21), 4582-4585. doi.org/10.1016/j.
vaccine.2005.08.027
Berz, D. W. (2011). Targeting the growth factors and
angiogenesis pathways: small molecules in solid
tumors. Journal of Surgical Oncology, 103(6), 574-
586. doi: 10.1002/jso.21776.
Blackwood L., M. T. (2012). European consensus
document on mast cell tumours in dogs and cats.
Veterinary and Comparative Oncology, 10(3), e1-e29.
doi: 10.1111/j.1476-5829.2012.00341.x
Boyle, G. D. (2014). Intra-lesional injection of the
novel PKC activator EBC-46 rapidly ablates tumors in mouse models. PLoS One, 9(10), e108887. doi:
10.1371/journal.pone.0108887.
Cawley, J. R., Wright, Z. M., Meleo, K., Post, G. S.,
Clifford, C. A., Vickery, K. R., Vail, D. M., Bergman,
P. J. & Thamm, D. H. (2020). Concurrent use of
rabacfosadine and L-asparaginase for relapsed or
refractory multicentric lymphoma in dogs. Journal
of Veterinary Internal Medicine, 34(2), 882-889.
Compte Grau, M., Ribas, A. & Sanz Alcocer, L. (2015).
Anticuerpos monoclonales: realidades y perspectivas
en el tratamiento del cáncer. En Inmunoterapia
del cáncer: Realidades y perspectivas (pp. 21-32).
Elsevier Inc.
Da Silva, D. M. (2014). Treatment of canine
transmissible venereal tumor using L-asparaginase,
prednisone, and surgery in a clinical chemotherapyresistant
case. Turkish Journal of Veterinary and
Animal Sciences, 38, 220-223. doi:10.3906/vet-
1309-23.
De Ridder, T. R.‐S. (2021). Randomized controlled
clinical study evaluating the efficacy and safety of
intratumoral treatment of canine mast cell tumors
with tigilanol tiglate (EBC‐46). Journal of veterinary
internal medicine, 35(1), 415-429.
Dorn, C. R. (1967). The epidemiology of cancer in
animals. California medicine, 107(6), 481.
Dow, S. & Guth, A. (2020). Cancer Immunotherapy. En
S: Withrow (ed.), Small Animal Clinical Oncology (pp.
231-250). Elsevier Inc.
Ehrhart, N. & Culp, W. (2012). Principles of surgical
oncology. En Veterinary Surgical Oncology (pp.
3-13). Wiley-Blackwell.
Farese, J. P., Baco, N. J., Liptak, J. M. & Kow, K. (2018).
Introduction to oncologic surgery for the general
surgeon. En Veterinary Surgery Small Animal (pp.
325-345). Elsevier Inc.
Fernandez De Queiroz, G. M. (2008). Clinical Study
of Cryosurgery Efficacy in the Treatment of Skin and
Subcutaneous Tumors in Dogs and Cats. Veterinary
Surgery, 37(5), 438-443. doi: 10.1111/j.1532-
950X.2008.00411.x
Gaspar, T. B., Henriques, J., Marconato, L. & Queiroga,
F. L. (2018). The use of low‐dose metronomic
chemotherapy in dogs-insight into a modern cancer
field. Veterinary and comparative oncology, 16(1),
2-11. doi.org/10.1111/vco.12309
Gajewski, T. F. (2017). Introduction to principles of
cancer immunotherapy. En Cancer immunotherapy
principles and practice (pp. 231-236). Demos
Medical.
Graham, G. F. (2001). Cryosurgery in the
management of cutaneous malignancies. Clinical
Dermatology, 19(3), 321-327. doi: 10.1016/s0738-
081x(01)00171-7.
Goldschmidt, M. H., Peña, L. & Zappulli, V.
(2016). Tumors of the mammary gland. Tumors
in domestic animals, 723-765. https://doi.
org/10.1002/9781119181200.ch17
Gustafson, D. L. & Bailey, D. B. (2020). Cancer
Chemotherapy. En S. Withrow (ed.), Small Animal
Clinical Oncology (pp. 182-208). Elsevier Inc.
Hauck, M. L. & Oblak, M. L. (2020). Tumors of the
skin and subcutaneous tissues. En S. Withrow (ed.),
Small Animal Clinical Oncology (pp. 352-366).
Elsevier Inc.
Huerta Yepez, S., Luria Perez, R. & Vega, M. I. (2016).
Respuesta inmunológica a tumores. En Inmunología
molecular, celular y traslacional (pp. 508-525). Wolters
Kluwer. Kiupel, M. W. (2011). Proposal of a 2-Tier
Histologic Grading System for Canine Cutaneous Mast
Cell Tumours to More Accurately Predict Biological
Behavior. Veterinary Pathology, 48(1), 147-55. doi:
10.1177/0300985810386469.
Kiupel, M. (2017). Mast cell tumors. En D. J. Meuten, Tumors
in domestic animals (pp. 176-193). Wiley Blackwell.
Klingemann, H. (2018). Immunotherapy for dogs: Running
behind humans. Frontiers in Immunology, 9, 133. doi:
10.3389/fimmu.2018.00133
Kroemer, G. G. (2014). Immunogenic Cell Death in Cancer
Therapy. Annual Review of Immunology, 31, 51-72. doi:
10.1146/annurev-immunol-032712-100008.
Larue, S. M. & Gordon, I. K. (2020). Radiation Oncology. En
S. Withrow (ed.), Small Animal Clinical Oncology (pp. 209-
230). Elsevier Inc.
London, A. C. (2009). Tyrosine Kinase Inhibitors in
Veterinary Medicine. Topics in Companion Animal
Medicine, 24 (3), 106-112. doi.org/10.1053/j.
tcam.2009.02.002
Manfred, S. (2017). Encyclopedia of Cancer. En
Encyclopedia of Cancer (pp. 2809-2812). Springer
Reference. doi.org/10.1007/978-3-662-46875-3
Misdorp, W. (2004). Mast cells and canine mast cells
tumours. A review. Veterinary Quarterly, 26(4), 156-69.
doi: 10.1080/01652176.2004.9695178
Mochel, J. P., Ekker, S. C., Johannes, C. M., Jergens, A. E.,
Allenspach, K., Bourgois-Mochel, A., Knouse, M., Benzekry,
S., Wierson, W., LeBlanc, A. K. & Kenderian, S. S. (2019).
CAR T Cell Immunotherapy in Human and Veterinary
Oncology: Changing the Odds Against Hematological
Malignancies. AAPS Journal, 21(3). doi.org/10.1208/
s12248-019-0322-1
Moore, S. A. (2002). Radiation Therapy for the
Treatment of Tumours in Small Companion Animals.
The Veterinary Journal, 164(3), 176-187. doi:
10.1053/tvjl.2002.0728
Murphy, S. (2001). Cutaneous Squamous Cell
Carcinoma in the Cat: Current understanding
and treatment approaches. Journal of Feline
Medicine and Surgery, 15(5), 401-407. doi:
10.1177/1098612X13483238
Mutsaers, A. J. & Biller, B. (2020). Molecular/Targeted
Therapy of cancer. En S. Withrow (ed.), Small Animal
Clinical Oncology (pp. 251-285). Elsevier Inc.
Nemec, A. M. (2020). Electroporation-Based
Treatments in Small Animal Veterinary Oral
and Maxillofacial Oncology. Frontiers in
Veterinary Science, 7, 575911. doi: 10.3389/
fvets.2020.575911.
Regan, D., Guth, A., Coy, J. & Dow, S. (2016). Cancer
immunotherapy in veterinary medicine: Current
options and new developments. The Veterinary
Journal, 207, 20-28. doi: 10.1016/j.tvjl.2015.10.008.
Schemelinin, I. Š. (2006). Protein Kinases, Their
Function and Implication in Cancer and Other
Diseases. Folia Biologica, 52(3), 81-100.
Singh, S., Tank, N. K., Dwiwedi, P., Charan, J., Kaur, R.,
Sidhu, P. & Chugh, V. K. (2018). Monoclonal antibodies.
A review. Current Clinical Pharmacology, 13(2), 85-99.
doi.org/10.2174/1574884712666170809124728
Sledge, D. W. (2016). Canine cutaneous mast cell
tumours: A combined clinical and pathologic approach to diagnosis, prognosis, and treatment selection.
The Veterinary Journal, 215, 43-54. doi: 10.1016/j.
tvjl.2016.06.003
Soderstrom, M. J. (1995). Principles of surgical oncology.
Veterinary Clinics: Small Animal Practice, 25(1), 97-
110. doi.org/10.1016/S0195-5616(95)50007-5
Sorenmo, K. (2003). Canine mammary gland tumors.
Veterinary Clinics: Small Animal Practice, 33(3), 573-
596. doi.org/10.1016/S0195-5616(03)00020-2
Spugnini, E. P. (2019). Electrochemotherapy in Veterinary
Oncology State-of-the-Art and Perspectives. Veterinary
Clinics of North America: Small Animal Practice, 49(5),
967-979. doi: 10.1016/j.cvsm.2019.04.006
Stefanello, D. B. (2015). Comparison of 2- and
3-category histologic grading systems for predicting
the presence of metastasis at the time of initial
evaluation in dogs with cutaneous mast cell tumors:
386 cases (2009-2014). Journal of the American
Veterinary Medical Association, 246(7), 765-769. doi:
10.2460/javma.246.7.765
Thamm, D. H. (2019). Novel Treatments for
Lymphoma. Veterinary Clinics of North America - Small
Animal Practice, 49(5), 903-915. doi.org/10.1016/j.
cvsm.2019.04.004
Wong Baeza, I. & Serafín López, J. (2016). Anticuerpos.
En Inmunología molecular, celular y traslacional (pp.
160-173). Wolters Kluwer.
World Health Organization (WHO). (20 de junio de
2021). Cancer. Recuperado de https://www.who.
int/health-topics/cancer#tab=tab_1
Zandvliet, M. (2016). Canine lymphoma: a
review. Veterinary Quarterly, 36(2), 76-104. doi:
10.1080/01652176.2016.1152633